Market Closed -
OTC Markets
02:36:11 2024-05-01 pm EDT
|
5-day change
|
1st Jan Change
|
0.0002
USD
|
0.00%
|
|
0.00%
|
-83.33%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
6.016
|
76.91
|
55.34
|
903.3
|
237.4
|
14.29
|
Enterprise Value (EV)
1 |
24.65
|
79.59
|
61.69
|
835.6
|
192.4
|
4.135
|
P/E ratio
|
-0.27
x
|
-5.53
x
|
-5.29
x
|
-7.22
x
|
-0.92
x
|
-0.15
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
2,895,156,699
x
|
66,037,226
x
|
5,684,016
x
|
EV / Revenue
|
-
|
-
|
-
|
2,678,050,929
x
|
53,517,059
x
|
1,644,636
x
|
EV / EBITDA
|
-1.3
x
|
-7.04
x
|
-6.91
x
|
-
|
-
|
-
|
EV / FCF
|
-2.75
x
|
-27.1
x
|
-37.5
x
|
-20.1
x
|
-2.05
x
|
-0.08
x
|
FCF Yield
|
-36.4%
|
-3.7%
|
-2.66%
|
-4.98%
|
-48.7%
|
-1,239%
|
Price to Book
|
-0.25
x
|
-9.48
x
|
-3.88
x
|
19.8
x
|
-10.1
x
|
-0.31
x
|
Nbr of stocks (in thousands)
|
2,989
|
21,975
|
22,704
|
51,617
|
63,818
|
119,080
|
Reference price
2 |
2.012
|
3.500
|
2.438
|
17.50
|
3.720
|
0.1200
|
Announcement Date
|
3/27/18
|
3/26/19
|
3/16/20
|
3/10/21
|
3/1/22
|
3/30/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
|
-
|
-
|
-
|
0.312
|
3.595
|
2.514
|
EBITDA
1 |
-18.98
|
-11.31
|
-8.925
|
-
|
-
|
-
|
EBIT
1 |
-19.03
|
-11.33
|
-8.944
|
-88.2
|
-232.8
|
-68.3
|
Operating Margin
|
-
|
-
|
-
|
-28,268.59%
|
-6,474.88%
|
-2,716.95%
|
Earnings before Tax (EBT)
1 |
-21.99
|
-12
|
-10.29
|
-89.54
|
-236.6
|
-70.73
|
Net income
1 |
-21.99
|
-12
|
-10.29
|
-89.54
|
-236.6
|
-70.73
|
Net margin
|
-
|
-
|
-
|
-28,697.12%
|
-6,582.73%
|
-2,813.44%
|
EPS
2 |
-7.341
|
-0.6334
|
-0.4603
|
-2.422
|
-4.043
|
-0.7926
|
Free Cash Flow
1 |
-8.97
|
-2.941
|
-1.643
|
-41.59
|
-93.7
|
-51.23
|
FCF margin
|
-
|
-
|
-
|
-13,331.33%
|
-2,606.38%
|
-2,037.78%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/27/18
|
3/26/19
|
3/16/20
|
3/10/21
|
3/1/22
|
3/30/23
|
Fiscal Period: December |
2020 Q4
|
2021 Q1
|
2021 Q2
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
---|
Net sales
1 |
0.312
|
0.486
|
1.036
|
1.036
|
1.037
|
1.036
|
1.036
|
0.221
|
0.221
|
0.221
|
EBITDA
|
-32.3
|
-64.4
|
-70.05
|
-65.98
|
-32.34
|
-20.53
|
-29.35
|
-22.72
|
4.297
|
-
|
EBIT
1 |
-32.3
|
-64.4
|
-70.05
|
-65.98
|
-32.34
|
-20.53
|
-29.35
|
-22.72
|
4.297
|
-4.235
|
Operating Margin
|
-10,350.96%
|
-13,250.21%
|
-6,761.78%
|
-6,368.63%
|
-3,119.09%
|
-1,981.56%
|
-2,833.11%
|
-10,281%
|
1,944.34%
|
-1,916.29%
|
Earnings before Tax (EBT)
1 |
-32.3
|
-65.57
|
-70.8
|
-66.74
|
-33.54
|
-21.28
|
-30.15
|
-23.69
|
4.39
|
-4.182
|
Net income
1 |
-32.3
|
-65.57
|
-70.8
|
-66.74
|
-33.54
|
-21.28
|
-30.15
|
-23.69
|
4.39
|
-4.182
|
Net margin
|
-10,350.96%
|
-13,491.15%
|
-6,834.27%
|
-6,441.99%
|
-3,234.33%
|
-2,053.86%
|
-2,910.14%
|
-10,720.81%
|
1,986.43%
|
-1,892.31%
|
EPS
2 |
-0.6300
|
-1.250
|
-1.200
|
-1.120
|
-0.5300
|
-0.3200
|
-0.4300
|
-0.2300
|
0.1600
|
-0.0400
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/10/21
|
5/13/21
|
8/12/21
|
11/12/21
|
2/28/22
|
5/5/22
|
8/12/22
|
11/14/22
|
3/30/23
|
5/15/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
18.6
|
2.68
|
6.34
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
67.7
|
45
|
10.2
|
Leverage (Debt/EBITDA)
|
-0.9815
x
|
-0.237
x
|
-0.7108
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
-8.97
|
-2.94
|
-1.64
|
-41.6
|
-93.7
|
-51.2
|
ROE (net income / shareholders' equity)
|
153%
|
74%
|
91.8%
|
-573%
|
-2,165%
|
201%
|
ROA (Net income/ Total Assets)
|
-372%
|
-466%
|
-591%
|
-160%
|
-209%
|
-104%
|
Assets
1 |
5.904
|
2.576
|
1.743
|
55.89
|
113.3
|
68.14
|
Book Value Per Share
2 |
-8.140
|
-0.3700
|
-0.6300
|
0.8800
|
-0.3700
|
-0.3900
|
Cash Flow per Share
2 |
0.2500
|
0.0400
|
0.0100
|
1.310
|
1.090
|
0.0900
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/27/18
|
3/26/19
|
3/16/20
|
3/10/21
|
3/1/22
|
3/30/23
|
|
1st Jan change
|
Capi.
|
---|
| -83.33% | 23.82K | | -4.14% | 86.85B | | +2.76% | 40.16B | | -16.48% | 31.28B | | +57.86% | 25.27B | | -13.58% | 15.33B | | -9.12% | 11.96B | | -42.56% | 11.61B | | +6.89% | 8.83B | | -10.53% | 7.94B |
Biopharmaceuticals
|